Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.

3d rendering of coronavirus in prison

Researchers at the University of Oxford, Department of Psychiatry, conducted a systematic review on managing outbreaks of highly contagious diseases in prisons, using 28 studies of investigations, which were all based in high-income countries with documented outbreaks of tuberculosis, influenza (types A and B), varicella, measles, mumps, adenovirus and COVID-19.

A number of challenges specific to managing infectious disease outbreaks in prisons were identified. Contact tracing in prisons is complicated by reluctance to disclose symptoms due to stigma, concerns about confidentiality, and fear of further restrictions, such as prolonged periods of medical isolation. Effective isolation and quarantine measures are difficult due to overcrowding, poor ventilation, sanitation and hygiene, which are common in many prisons. Prisons can easily become a reservoir for COVID-19 infection to the community as turnover is high and transmission can occur at multiple points including via staff. In addition, people in prison have higher rates of many physical and mental health comorbidities, consistently shown to be more common than in community persons of similar age. Thus, the paper recommends a coordinated approach to managing outbreaks in these settings with prisons and public health authorities working closely.

Professor Seena Fazel, Department of Psychiatry, University of Oxford, said,

 

‘Prisons are high-risk settings for the transmission of contagious diseases and there are considerable challenges in managing outbreaks in them. Our research suggests that people in prison should be among the first groups to receive any COVID-19 vaccine to protect against infection and to prevent further spread of the disease. The prison population is generally at higher risk of complications from infection because of the increased prevalence of underlying health conditions, and the overrepresentation of marginalised groups that have been disproportionately affected by COVID-19. A public health approach to managing COVID-19 in prisons is important now and for any future infectious disease outbreaks.’

The research highlights some important actions which health authorities and prisons should do including:

  • Sharing clear and up-to-date information about health risks, prevention and control measures with people in prisons and correctional staff
  • Assessing the benefits of prolonged infection control strategies against the potential negative consequence of such measures on the mental health of the prison population
  • Ensuring that people in prison are released to safe and suitable housing, to ensure that transmission risks are reduced.

According to the New York Times (16 November 2020), more than 252,000 people in prisons and jails have tested positive for COVID-19, and at least 1,450 have died from complications.  In the UK (31 October 2020), the Ministry of Justice reports 55 COVID-related deaths of people in prison. Since the start of the pandemic, there have been 1,529 positive cases in the prison population in England and Wales across 99 establishments.

The research involved a collaboration between infectious diseases and mental health researchers in the US, UK and China, and was partly funded by the Wellcome Trust.

To read the full paper, Managing outbreaks of highly contagious diseases in prisons: a systematic review.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New UK Pandemic Ethics Accelerator Brings Ethical Thinking into Pandemic Policy-Making

COVID-19

The UK Pandemic Ethics Accelerator, which launched today, harnesses and mobilises the UK’s internationally renowned expertise in ethics research. Four major UK universities and the Nuffield Council on Bioethics form the collaborative.

Risk of Rare Blood Clotting Higher for COVID-19 than for Vaccines

COVID-19

Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.

No Evidence of Significant Increase in Risk of Suicide in First Months of Pandemic

COVID-19 Mental Health Suicide

A new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic in multiple countries and finds that suicide numbers largely remained unchanged or declined in the pandemic’s early months, however continued monitoring is needed.

Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions

COVID-19 Mental Health

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates.

Opportunities for Final Goodbyes Must be Prioritised in COVID-19 Pandemic

COVID-19 Child and Adolescent Psychiatry Mental Health

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

Seven in Ten Patients Hospitalised with COVID-19 Not Fully Recovered After Five Months

COVID-19 Mental Health

The majority of survivors who left hospital following COVID-19 did not fully recover five months after discharge and continued to experience negative impacts on their physical and mental health, as well as ability to work, according to results released by the PHOSP-COVID study.